BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Clinical Outcome
2 results:

  • 1. Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.
    Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; VavalĂ  T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G
    Oncotarget; 2015 May; 6(14):12783-95. PubMed ID: 25904052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic value of FHIT, ctnnb1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.